行情

NUWE

NUWE

Nuwellis Inc
NASDAQ

实时行情|Nasdaq Last Sale

2.440
-0.160
-6.15%
盘后: 2.500 +0.06 +2.46% 18:49 09/20 EDT
开盘
2.460
昨收
2.600
最高
2.550
最低
2.410
成交量
25.55万
成交额
--
52周最高
12.57
52周最低
2.410
市值
2,443.69万
市盈率(TTM)
-0.4637
分时
5日
1月
3月
1年
5年
Nuwellis, Inc. 宣布完成 1,000 万美元的普通股承销公开发售,包括全面行使超额配股权
EDEN PRAIRIE, Minn., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE) (the “Company”) announced today the closing of its previously announced underwritten public offering of 4,005,588 shares of its common stock at a price to the public of $2...
GlobeNewswire · 3天前
为什么 Nuwellis 股价今天走低
Nuwellis (NASDAQ:NUWE) shares are trading lower after the company announced it priced a 3,483,120 share common stock offering at $2.50 per share.
Benzinga · 5天前
午后市场更新:道指上涨 250 点; GreenSky 股价飙升
Toward the end of trading Wednesday, the Dow traded up 0.72% to 34,827.73 while the NASDAQ rose 0.58% to 15,125.38. The S&P also rose, gaining 0.82% to 4,479.33.
Benzinga · 5天前
YY、NNVC 和 REKR 处于午盘走势中
Gainers: GreenSky (NASDAQ:GSKY) +53%. IronNet (NYSE:IRNT) +27%. Sphere (NASDAQ:ANY) +22%. Allied Healthcare Products (NASDAQ:AHPI) +19%. Actinium Pharmaceuticals (NYSE:ATNM) +16%. Ampio Pharmaceuticals (NYSE:AMPE) +15%. Inozyme Pharma (NASDAQ:INZY) +15%. S...
Seekingalpha · 5天前
38 只股票在周三的午盘交易中移动
Gainers Indaptus Therapeutics, Inc. (NASDAQ: INDP) shares jumped 177.2% to $19.60 after the company announced the United States Patent and Trademark Office has issued a notice of allowance for claims related to the company's platform technology.
Benzinga · 5天前
Ampio Pharmaceuticals, 180 Life Sciences 领跑医疗保健赢家; Nuwellis 和 Berkeley Lights 是主要输家
Gainers: Ampio Pharmaceuticals (NYSE:AMPE) +22%, 180 Life Sciences (NASDAQ:ATNF) +17%, Brainstorm Cell Therapeutics (NASDAQ:BCLI) +15%, Instil Bio (NASDAQ:TIL) +16%, G Medical Innovations (NASDAQ:GMVD) +15%. Losers: Nuwellis (NASDAQ:NUWE) -26%, Berkeley Li...
Seekingalpha · 5天前
早盘市场更新:市场喜忧参半; 8 月份工业生产增长 0.4%
Following the market opening Wednesday, the Dow traded up 0.13% to 34,621.78 while the NASDAQ fell 0.25% to 14,999.72. The S&P also rose, gaining 0.03% to 4,444.41.
Benzinga · 5天前
Melco Resorts & Entertainment、Hut 8 Mining、Theravance Biopharma 跻身上市前失败者之列
Nuwellis (NASDAQ:NUWE) -28% after proposes stock offering Theravance Biopharma (NASDAQ:TBPH) -20% after ampreloxetine misses primary endpoint in late-stage orthostatic; on headcount cut to focus on respiratory disease portfolio hypotension study DAVIDsTEA ...
Seekingalpha · 5天前
更多
财务预测
实际值(万 美元)
预测值(万 美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解NUWE最新的财务预测,通过NUWE每股收益,每股净资产,每股现金流等数据分析Nuwellis Inc近期的经营情况,然后做出明智的投资选择。
分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测NUWE价格均价为13.42,最高价位22.25,最低价为6.00。
EPS
机构持股
总机构数: 26
机构持股: 89.36万
持股比例: 8.92%
总股本: 1,001.51万
类型机构数股数
增持
5
3.05万
建仓
4
11.31万
减持
2
6,602
平仓
4
81.92万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
先进医疗设备和技术
-1.76%
医疗设备和用品
-1.59%
高管信息
Chairman/Director
John Erb
President/Chief Executive Officer
Nestor Jaramillo
Chief Financial Officer
George Montague
Senior Vice President/Chief Compliance Officer/General Counsel/Secretary
Neil Ayotte
Chief Accounting Officer/Controller
Paul Wotta
Lead Director/Independent Director
Warren Watson
Independent Director
Steven Brandt
Independent Director
Maria Costanzo
Independent Director
Jon Salveson
Independent Director
Gregory Waller
暂无数据
NUWE 简况
Nuwellis Inc(原名:CHF Solutions Inc)是一家医疗器械公司。该公司专注于开发、制造和商业化用于超滤疗法的Aquadex SmartFlow系统,该系统可轻柔地去除液体并恢复遭受液体超负荷的患者的平衡。Aquadex SmartFlow系统适用于体重在20公斤或以上的成年和儿科患者的短期或长期使用,其体液超负荷对包括利尿剂在内的医疗管理无效。Aquadex系统由三部分组成:控制台,允许看护者控制超滤疗法;外围导管从患者身上抽血并将血液返回患者体内,而血液回路套件则可以过滤患者的血液并收集多余的水和盐分。它的解决方案还包括RenalSense Clarity RMS,它是一种肾脏监测系统,可连续测量尿液的排出量和流量,并自动向医务人员显示实时数据。

微牛提供Nuwellis Inc(NASDAQ-NUWE)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的NUWE股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易NUWE股票基本功能。